Finance

Beta
Lists
BLTE:NASDAQ
Belite Bio Inc
$146.12
-1.50%
(-2.22) 1D
$146.12
0.00% (0.00)
After hours
Closed: Jun 18, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BLTE...
Open
$149.00
High
$151.99
Low
$143.90
Mkt. cap
5.86B
Avg. vol.
219.30K
Volume
255.11K
52-wk high
$200.00
52-wk low
$56.10
EPS
-$2.65
Beta
-1.24
Shares outstanding
39.96M
No. of employees
41
Open
$149.00
High
$151.99
Low
$143.90
Mkt. cap
5.86B
Avg. vol.
219.30K
Volume
255.11K
52-wk high
$200.00
52-wk low
$56.10
EPS
-$2.65
Beta
-1.24
Shares outstanding
39.96M
No. of employees
41
Analyst outlook
Analyst Ratings
Based on 5 analysts giving stock ratings to BLTE in the past 3 months
Strong Buy
Buy
5
Hold
0
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for BLTE in the last 3 months.
Highest
Current $146.12
$266.00 (+82.04%)
Average
$216.20 (+47.96%)
Lowest
$200.00 (+36.87%)
News stories
From sources across the web
About Belite Bio Inc
CEO-
Employees41
Founded2016
Headquarters-
SectorPharmaceutical industry
Websitebelitebio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
11.05M
10.31M
14.62M
15.66M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.55M
12.71M
13.45M
17.02M
Operating expense
17.60M
23.02M
28.08M
32.68M
Total operating expenses
17.60M
23.02M
28.08M
32.68M
Operating income
-17.60M
-23.02M
-28.08M
-32.68M
Other non operating income
1.28M
-2.14M
-417.00K
5.75M
EBT including unusual items
-16.32M
-21.69M
-25.32M
-26.94M
EBT excluding unusual items
-16.32M
-21.69M
-25.32M
-26.94M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-16.32M
-21.69M
-25.32M
-26.94M
Net profit margin
-
-
-
-
Earnings per share
-0.50
-0.65
-0.70
-0.68
Interest and investment income
-
3.47M
3.17M
-
Interest expense
-
-
-2.00K
-
Net interest expenses
-
3.47M
3.17M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-17.55M
-22.97M
-28.03M
-32.64M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer